Hyperliquid Strategies Inc (PURR) - What Are Brokerages Thinking About This Stock?

Key Points

• Analysts broadly favor Hyperliquid Strategies: Five firms have a consensus “Buy” rating, with three buys, one strong buy, and one hold. The average 12-month price target is $19.80, though targets range from $17.00 to $34.20 and one firm downgraded the stock to “sell.”
• Institutional ownership is limited but increasing: Several hedge funds raised their positions during the third quarter, while institutional investors collectively own 9.45% of the company.
• The stock has been volatile: PURR opened at $9.71 after an 11.8% decline, compared with a 12-month range of $3.01 to $14.76. Hyperliquid Strategies operates as a digital-asset treasury company focused on accumulating HYPE, the native token of the Hyperliquid blockchain.

Shares of Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $19.80.

A number of analysts have weighed in on the company. Chardan Capital raised their price target on Hyperliquid Strategies from $9.75 to $17.00 and gave the company a "buy" rating in a research note on Friday, August 28th. Cantor Fitzgerald upped their price objective on Hyperliquid Strategies from $22.60 to $34.20 and gave the stock an "overweight" rating in a research report on Thursday, September 10th. Weiss Ratings cut Hyperliquid Strategies from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, October 23rd. Wall Street Zen downgraded Hyperliquid Strategies from a "hold" rating to a "sell" rating in a report on Sunday, October 11th. Finally, Compass Point began coverage on Hyperliquid Strategies in a research report on Monday, September 14th. They set a "buy" rating and a $18.00 target price on the stock.

Hedge Funds Weigh In On Hyperliquid Strategies

Hedge funds have recently added to or reduced their stakes in the stock. Sterling Capital Management LLC grew its position in shares of Hyperliquid Strategies by 48.5% in the 3rd quarter. Sterling Capital Management LLC now owns 3,762 shares of the company's stock valued at $46,000 after buying an additional 1,229 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in Hyperliquid Strategies by 9.2% during the 3rd quarter. Commonwealth Equity Services LLC now owns 16,242 shares of the company's stock worth $199,000 after acquiring an additional 1,372 shares in the last quarter. Vima LLC lifted its position in Hyperliquid Strategies by 202.7% in the third quarter. Vima LLC now owns 5,364 shares of the company's stock valued at $66,000 after acquiring an additional 3,592 shares during the last quarter. Profund Advisors LLC lifted its position in Hyperliquid Strategies by 4.2% in the third quarter. Profund Advisors LLC now owns 91,907 shares of the company's stock valued at $1,128,000 after acquiring an additional 3,712 shares during the last quarter. Finally, State of Wyoming purchased a new stake in Hyperliquid Strategies in the second quarter valued at $46,000. 9.45% of the stock is currently owned by hedge funds and other institutional investors.

Hyperliquid Strategies Trading Down 11.8%

Shares of PURR stock opened at $9.71 on Tuesday. The firm has a fifty day moving average price of $11.41 and a 200 day moving average price of $8.00. The company has a market cap of $2.70 billion, a P/E ratio of -1.51 and a beta of 1.89. Hyperliquid Strategies has a 12 month low of $3.01 and a 12 month high of $14.76.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.